Mucosal Administration of
Avian influenza
HA1
Lactobacillus casei
mucosal delivery
poly γ-glutamic acid synthetase A
surface display
Journal
Journal of microbiology and biotechnology
ISSN: 1738-8872
Titre abrégé: J Microbiol Biotechnol
Pays: Korea (South)
ID NLM: 9431852
Informations de publication
Date de publication:
31 Oct 2023
31 Oct 2023
Historique:
received:
28
07
2023
revised:
12
10
2023
accepted:
18
10
2023
medline:
2
11
2023
pubmed:
2
11
2023
entrez:
2
11
2023
Statut:
aheadofprint
Résumé
Avian influenza is a serious threat to both public health and the poultry industry worldwide. This respiratory virus can be combated by eliciting robust immune responses at the site of infection through mucosal immunization. Recombinant probiotics, specifically lactic acid bacteria, are safe and effective carriers for mucosal vaccines. In this study, we engineered recombinant fusion protein by fusing the hemagglutinin 1 (HA1) subunit of the A/Aquatic bird/Korea/W81/2005 (H5N2) with the
Identifiants
pubmed: 37915251
pii: jmb.2307.07040
doi: 10.4014/jmb.2307.07040
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM